@article {1257, title = {Chemopreventive Action of Garcinia Mangostana Linn. on Hepatic Carcinoma by Modulating Ornithine Decarboxylase Activity}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {September 2020}, pages = {1383-1388}, type = {Research Article}, chapter = {1383}, abstract = {

Ornithine decarboxylase and alpha -L- fucosidase over-expression is associated with advanced hepatocellular carcinoma (HCC) development. The objective of this study was to elucidate the action of Garcinia Mangostana fruit extract (GME) on these overexpressed enzymes and apoptotic proteins in diethyl nitrosamine (DEN) induced hepatocellular carcinoma (HCC) rats. The cancer was induced using DEN to the experimental rats and treated with GME (400 mg/ kg) to find its anticancer property. The lysosomal enzymes such as alpha-L-fucosidase, beta- D-glucosidase, ornithine decarboxylase activity (ODC), apoptotic and antiapoptotic proteins such as Bcl-2, Bax and Bcl-xl and H3 thymidine incorporation assay were done to prove GME{\textquoteright}s chemo preventive property. DEN induction caused significant increase in the activities of ornithine decarboxylase; lysosomal enzymes and increased cell proliferation with decreased apoptosis were observed. In contrast, the groups with GME treated rat{\textquoteright}s elicited significant (P \< 0.001) reduction in ornithine decarboxylase, lysosomal enzymes and decreased cell proliferation with increased apoptosis. GME has effective chemo preventive property and can serve as an anticarcinogenic therapeutic drug against hepatocellular carcinoma.

}, keywords = {Diethyl nitrosamine, G. Mangostana extract, Hepatocellularcarcinoma, Ornithine decarboxylase}, doi = {10.5530/pj.2020.12.191}, author = {Vishnu Priya Veeraraghavan and Sardar Hussain and Janardhana Papayya Balakrishna and Gayathri Rengasamy and Surapaneni Krishna Mohan} } @article {1207, title = {Paronychia argentea: A Critical Comprehensive Review on its Diverse Medicinal Potential and Future as Therapeutics}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {August 2020}, pages = {1172-1179}, type = {Review Article}, chapter = {1172}, abstract = {

Background: Paronychia argentea has been used since long as a traditional medicine for the treatment of diabetes, kidney stones, anti-microbial and many other human diseases. However, the plant has not been explored much. In the present scenario of drug resistance and toxicity associated with available drugs, there is a need for elaborated studies of plants like Paronychia argeneta which had been used as folk medicines. Aim and Objectives: The present article is focused on reviewing the ethnopharmacology, phytochemistry, traditional usage, biological activities, of Paronychia argentea which has been used in traditional medicinal system for ages. The aim of the study was to assess the ethnopharmacological usage of this plant and to explore therapeutic potentials and future opportunities for research. Materials and Methods: Information on the traditional usage and studies of the Paronychia argentea was gathered from from various journals, MSc dissertation, conference abstract, local books. Various search engines including Google Scholar, Baidu Scholar, Elsevier, ACS, Pubmed, Web of Science, CNKI and EMBASE were used to collect the information along with libraries. Results: Paronychia argentea has played an important role in traditional medicines in Algeria, Portugal, Israel and Jordan. The aerial parts of this plant are used as diuretics in Algerian traditional medicines and are used as antiurolithiasis. Leaf decoction of this plant is also used as diuretic. Paronychia argentea has been used as analgesic, treatment of stomach ulcer, anorexia, and flatulence in Portugal. Scientific studies on extracts of Paronychia revealed a wide range of pharmacological activities including anti-microbial activity, anti-oxidant, nephroprotective activity. Moreover, few reports have given contradictory data for usage of Paronychia when compared with its traditional usage. As in the case of alpha-amylase inhibitory efficacy of PA, it was observed that PA inhibits alpha-amylase activity but later on it was proven that PA does not have a hypoglycemic effect. Main bioactive metabolites present in this plant include alkaloids, flavonoids, volatile oils, etc. Conclusions: Based on this review, there are evidences from various studies regarding pharmacological effects of this plant as nephroprotective, anti-oxidant, anti-microbial activity. Some indications from in vitro studies have confirmed the inhibitory activity of this plant extract against alpha amylase enzyme. The available literature showed that most of the activities of the Paronychia can be accredited to the flavonoids present in them. Data regarding mechanisms of action of this plant along with pharmacokinetics, toxicology studies is still limited, which indicate the need of such studies for the clinical usage of this plant.

}, keywords = {Anti-microbial, Anti-oxidant, Bioactivity, Herbal medicine, Nephroprotective, Oxidative stress, Paronychia argentea, Therapeutic value, Ulcerative colitis}, doi = {10.5530/pj.2020.12.165}, author = {Vishnu Priya Veeraraghavan and Sardar Hussain and Janardhana Papayya Balakrishna and Surapaneni Krishna Mohan} } @article {922, title = {Phytochemical Screening, HPTLC Fingerprinting and Invitro Antioxidant Activity of Root Extract of Asparagus racemosus}, journal = {Pharmacognosy Journal}, volume = {11}, year = {2019}, month = {July 2019}, pages = {818-823}, type = {Original Article}, chapter = {818}, abstract = {

Background: Asparagus racemosus is a climber shrub used in Indian medicine for centuries. It has been used as galactogogue and nerve tonic in folk medicine. The recent research on A. racemosus has revealed its disease fighting properties such as anti-bacterial, immunomodulatory, cardio protective, anti-stress, etc. Phytochemicals present in the plants are associated with their therapeutic capabilities. Hence, phytochemical screening of a therapeutic plant is essential. Materials and Methods: A preliminary qualitative screening of phytoconstituents present in the ethanol and aqueous extract of the plant was done. high-performance thin layer chromatography (HPTLC) was used to create a phytochemical fingerprint of the plant extract. Further, a series of antioxidant assays, i.e., 2,2-diphenyl-1- picrylhydrazyl (DDPH) radical, Nitric oxide (NO) radical, Superoxide (SO) radical and 2,2{\textquoteright}-azinobis( 3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging assays were done. Results: The phytochemical screening and the HPTLC fingerprint showed the presence of phenolic compounds, flavonoids, glycosides, triterpenoids, saponins etc. They also showed free radical scavenging property and hence can be used as potential primary antioxidant. Conclusion: A preliminary screening created a phytochemical profile of A. racemosus extracts. These phytoconstituents may be linked to the various known therapeutic applications of the plant. This may aid in further extensive studies for identifying and isolating compounds with potential therapeutic value in A. racemosus.

}, keywords = {Antioxidants, Asparagus racemosus, Chromatography, Phytochemistry, Phytoconstituents, Therapeutics}, doi = {10.5530/pj.2019.11.131}, author = {Kalaivani Selvaraj and Girija Sivakumar and Aruthra Arumugam Pillai and Vishnu Priya Veeraraghavan and Srinivasa Rao Bolla and Geetha Royapuram Veeraraghavan and Gayathri Rengasamy and Joel P Joseph and Janardhana PB} }